Wealth Alliance Advisory Group, LLC Gain Therapeutics, Inc. Transaction History

Wealth Alliance Advisory Group, LLC

  • $439 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023
SELL
$3.18 - $5.16 $19,871 - $32,244
-6,249 Reduced 33.33%
12,502 $60,000
Q4 2022

Jan 17, 2023
SELL
$2.89 - $3.35 $18,059 - $20,934
-6,249 Reduced 25.0%
18,751 $0
Q3 2022

Oct 12, 2022
BUY
$3.17 - $4.21 $79,250 - $105,250
25,000 New
25,000 $82,000

Others Institutions Holding GANX

# of Institutions
27
Shares Held
2.77M
Call Options Held
0
Put Options Held
0
View Full List

About Gain Therapeutics, Inc.

GANX Quotes by TradingView
  • Ticker GANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,883,400
  • Market Cap $32.4M
  • Description
  • Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...
More about GANX
Track This Portfolio

Track Wealth Alliance Advisory Group, LLC Portfolio

Follow Wealth Alliance Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance Advisory Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email